Generative AI in drug development
by Giuliana Miglierini Generative AI is perhaps the more advanced form of artificial intelligence available today, as it…
EMA’s reflection paper on AI in the pharmaceutical lifecycle
by Giuliana Miglierini The rapidly evolving role of artificial intelligence (AI) and its possible application in the pharmaceutical…
How to approach drug substance supply in new product introduction (NPI) processes
by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
ACT EU’s Workplan 2022-2026
by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…
EIC: challenges for the governance and opportunities for innovation
by Giuliana Miglierini The European Innovation Council (EIC) was launched in March 2021 by the EU Commission to…